Genome Editing/Genome Engineering Global Market Observe Highest Growth of $17.16 Billion with an Excellent CAGR of 18.9% by 2028

The genome editing/genome engineering global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Genome Editing/Genome Engineering Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –
The genome editing/genome engineering market size has grown rapidly in recent years. It will grow from $7.23 billion in 2023 to $8.57 billion in 2024 at a compound annual growth rate (CAGR) of 18.6%.  The  growth in the historic period can be attributed to increasing research in genetics and genomics, rise in genetic diseases, gene therapy advancements, investments in biotechnology and life sciences, potential for agricultural applications, application in model organisms.

The genome editing/genome engineering market size is expected to see rapid growth in the next few years. It will grow to $17.16 billion in 2028 at a compound annual growth rate (CAGR) of 18.9%.  The growth in the forecast period can be attributed to emergence of prime editing, focus on ethical and regulatory frameworks, increasing adoption in drug discovery, therapeutic potential for genetic disorders, customization for gene function studies, growing interest in epigenome editing. Major trends in the forecast period include advancements in crispr technology, growing applications in therapeutics, emergence of new genome editing tools, investments and partnerships, enhanced delivery systems, integration of artificial intelligence (ai) in genome editing design.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/genome-editing-or-genome-engineering-global-market-report

Scope Of Genome Editing/Genome Engineering Market
The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Genome Editing/Genome Engineering Market Overview

Market Drivers –
The rise in the prevalence of cancer and other genetic disorders is expected to propel the growth of the genome editing/genome engineering market going forward. Cancer is a condition wherein a few of the body’s cells grow out of control and spread to other body regions. Genome editing can quickly engineer immune cells and oncolytic viruses for cancer therapeutic applications. For instance, in February 2022, according to an article published by the World Health Organization (WHO), a Switzerland-based United Nations health agency, nearly 10 million deaths, or nearly one in six deaths, were caused by cancer, making it the leading cause of death worldwide. Further, in June 2022, according to a report published by the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, 1,752,735 new cases of invasive cancer in total, including 863,830 women and 888,905 men, were reported in the US in 2019. The incidence rate for all cancers was 439 per 100,000 people in the general population. Therefore, the rise in the prevalence of cancer and other genetic disorders is driving the growth of the genome editing and genome engineering market.

Market Trends –
Technological advancements in gene editing are a key trend gaining popularity in the genome editing/genome engineering market. Major companies operating in the genome editing/genome engineering market are concentrating on creating innovative technology solutions to improve their position. For instance, in May 2022, researchers at Kyoto University and the Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra), a Spain-based research university focused on evolutionary biology, unveiled a quick and effective method for editing genes in insects. Direct parental CRISPR (DIPA-CRISPR), a simple and effective method, involves injecting materials into developing eggs in female adults rather than embryos. The novel technique enables researchers to avoid microinjecting CRISPR material into insect embryos.

The genome editing/genome engineering market covered in this report is segmented –
1) By Product And Service: Reagents And Consumables, Software And systems, Services
2) By Technology: CRISPR, TALEN, ZFN, Antisense, Other Technologies
3) By Application: Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery And Development, Other Applications
4) By End User: Biotechnology Companies, Pharmaceutical Companies, Academic And Government Research Institutes

Get an inside scoop of the genome editing/genome engineering market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8010&type=smp

Regional Insights –
North America was the largest region in the gene editing/genome engineering market in 2023. Asia-Pacific is expected to be the fastest-growing region in the genome editing/genome engineering market report during the forecast period. The regions covered in the genome editing/genome engineering market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –
Major companies operating in the genome editing/genome engineering market report are Thermo Fisher Scientific Inc., Merck Group, Genscript Biotech Corp, Sangamo Therapeutics Inc., Lonza Group AG, Editas Medicine Inc., CRISPR Therapeutics AG, Agilent Technologies Inc., Intellia Therapeutics, bluebird bio Inc., Transposagen Biopharmaceuticals Inc., Tecan Trading AG, Precision BioSciences, PerkinElmer Inc., Cellectis S.A, Applied StemCell Inc., Bio-Rad Laboratories Inc., Bio-Techne, Creative Biogene, Cyagen Biosciences, Dharmacon Inc., Eurofins Genomics LLC, Evotec SE, GeneCopoeia Inc., Genewiz, Horizon Discovery Group plc, Inscripta Inc., Integrated DNA Technologies Inc., MaxCyte Inc., New England Biolabs, Novartis International AG.

Table of Contents
1. Executive Summary
2. Genome Editing/Genome Engineering Market Report Structure
3. Genome Editing/Genome Engineering Market Trends And Strategies
4. Genome Editing/Genome Engineering Market – Macro Economic Scenario
5. Genome Editing/Genome Engineering Market Size And Growth
…..
27. Genome Editing/Genome Engineering Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the trending research reports from TBRC
https://topprnews.com/gluten-feed-market

https://topprnews.com/organic-feed-market

https://topprnews.com/organic-pigments-market

https://goodprnews.com/rapeseed-oil-market

https://goodprnews.com/gluten-feed-market

https://goodprnews.com/manufactured-soil-market

 Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info

Healthcare Blog: https://healthcareresearchreports.com

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model